The Russian Direct Investment Fund (RDIF) applied for registration of the Sputnik V vaccine in the European Union on January 29, 2021, and scientific consultations with the European Medicines Agency (EMA) were held on January 19, the fund’s representative told reporters.
"RDIF submitted an application to EMA to participate in a scientific consultation on the Sputnik V vaccine on October 22, 2020. Representatives of the fund, vaccine developers, and EMA representatives held the scientific consultation on January 19. RDIF applied for registration of the Sputnik V vaccine in the European Union on January 29, 2021, and launched the process of submitting information to the EMA through a rolling review procedure," the fund said.
Earlier this year the Sputnik V vaccine was registered in Hungary, UAE, Setrbia, Argentina and 15 other countries. By the end of the week, the Sputnik V vaccine can be registered in 25 countries.
Ministry of Industry
and Trade of Russia
and Trade of Russia